Prognostic factors of myxofibrosarcomas: Implications of margin status, tumor necrosis, and mitotic rate on survival

Journal of Histotechnology

Volumn 28, Issue 4, 2006, Pages 294-303

  Lin, Ching Nan ^a   Chou, Shin Cheng ^b   Li, Chien Feng ^a   Tsai, Kun Bow ^c   Chen, Wen Chung ^d   Hsiung, Ching Yeh ^e   Yen, Cheng Fang ^f   Huang, Hsuan Ying ^e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Margin status; Multivariate survival analyses; Myxofibrosarcoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FIBROMYXOSARCOMA; FIBROSARCOMA; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MITOSIS RATE; PROGNOSIS; TUMOR GROWTH; TUMOR NECROSIS; ADOLESCENT; CANCER STAGING; MIDDLE AGED; MITOSIS INDEX; MORTALITY; MULTIVARIATE ANALYSIS; MYXOSARCOMA; NECROSIS; PATHOLOGY; PREDICTION AND FORECASTING; SOFT TISSUE TUMOR; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FIBROSARCOMA; HUMANS; LIPOSARCOMA, MYXOID; MALE; MIDDLE AGED; MITOTIC INDEX; MULTIVARIATE ANALYSIS; MYXOSARCOMA; NECROSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33644666011     PISSN: 01478885     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20425     Document Type: Article

References (22)

1. Mentzel T, van den Berg E, Molenaar WM: Myxofibrosarcoma. In: Fletcher CDM, Unni KK, Mertens F, editors. WHO classification of tumors - Pathology and genetics, tumors of soft tissue and bone. Lyon: IARC press; 2002. pp 102-103.
2. Weiss SW, Enzinger FM: Myxoid variant of malignant fibrous histiocytoma. Cancer 1977;39:1672-1685.
3. Mentzel T, Calonje E, Wadden C, et al.: Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996;20:391-405.
4. Kindblom LG, Merck C, Angervall L: The ultrastructure of myxofibrosarcoma. A study of 11 cases. Virchows Arch A Pathol Anat Histol 1979;381:121-139.
5. Huang HY, Lal P, Qin J, et al.: Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol 2004;35:612-621.
6. Angervall L, Kindblom LG, Merck C: Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand [A] 1977;85A:127-140.
7. Oda Y, Takahira T, Kawaguchi K, et al.: Altered expression of cell cycle regulators in myxofibrosarcoma, with special emphasis on their prognostic implications. Hum Pathol 2003;34:1035-1042.
8. Merck C, Angervall L, Kindblom LG, et al.: Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis. Acta Pathol Microbiol Immunol Scand Suppl 1983;282:1-40.
9. Huang HY, Brennan MF, Singer S, et al.: Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: A clinicopathological study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation. Mod Pathol 2005;18:976-984.
10. Antonescu CR, Elahi A, Humphrey M, et al.: Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: Absence in predominantly myxoid well-differentiated liposarcomas. J Mol Diagn 2000;2:132-138.
11. Hornick JL, Bosenberg MW, Mentzel T, et al.: Pleomorphic liposarcoma: Clinicopathologic analysis of 57 cases. Am J Surg Pathol 2004;28:1257-1267.
12. Lewis JJ, Antonescu CR, Leung DH, et al.: A multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 2000;18:2087-2094.
13. Gronchi A, Casali PG, Mariani L, et al.: Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: A series of patients treated at a single institution. J Clin Oncol 2005;23:96-104.
14. Guillou L, Coindre JM, Bonichon F, et al.: Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997;15:350-362.
15. American Joint Committee on Cancer, editors: Cancer staging manual, 6th edn. Philadelphia: Lippincott-Raven; 2002.
16. Zagars GK, Ballo MT, Pisters PW, et al.: Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: An analysis of 1,225 patients. Cancer 2003;97:2530-2543.
17. Gustafson P: Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl 1994;259:1-31.
18. Trovik CS, Bauer HC, Alvegard TA, et al.: Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000;36:710-716.
19. Ramanathan RC, A'Hern R, Fisher C, et al.: Prognostic index for extremity soft tissue sarcomas with isolated local recurrence. Ann Surg Oncol 2001;8:278-289.
20. Ferguson PC, Deshmukh N, Abudu A, et al.: Change in histological grade in locally recurrent soft tissue sarcomas. Eur J Cancer 2004;40:2237-2242.
21. Miyajima K, Oda Y, Oshiro Y, et al.: Clinicopathological prognostic factors in soft tissue leiomyosarcoma: A multivariate analysis. Histopathology 2002;40:353-359.
22. Trassard M, Le Doussal V, Hacene K, et al.: Prognostic factors in localized primary synovial sarcoma: A multicenter study of 128 adult patients. J Clin Oncol 2001;19:525-534.